Key points are not available for this paper at this time.
Vildagliptin is an incretin degradation inhibitor that improves beta-cell function in diabetic patients by increasing the insulin secretory tone.
Share your take
Add a clinician perspective alongside expert commentary.
Mari et al. (2005) studied this question.